|  Download for Citation Managers
CORRIGENDUM
Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
Year : 2022 | Volume: 5 | Issue Number: 3 | Page: 110-111
Click here to read this article
|
| |
|
